Timing and survival benefits of cytoreduction in patients with recurrent leiomyosarcoma
CRS provided a modest survival benefit for patients with recurrent LMS, although statistical significance was not achieved. The results of this study indicate that the timing of recurrence plays a crucial role in survival.
Authors
- Hüseyin Akıllı (ORCID: https://orcid.org/0000-0002-5240-8441)
- Ali̇ Ayhan (ORCID: https://orcid.org/0000-0001-7155-9096)
- Mehmet Tunç (ORCID: https://orcid.org/0000-0002-8646-0619)
- Esra Kuşçu (ORCID: https://orcid.org/0000-0002-0992-6980)
Institutions
- Başkent University (TR)
Publication Details
- Journal
- Archives of Gynecology and Obstetrics
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1007/s00404-025-08140-1
- Primary Topic
- Uterine Myomas and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00